Abeona Therapeutics (ABEO) Raw Materials (2025 - 2026)
Abeona Therapeutics' (ABEO) quarterly Raw Materials came in at $5.5 million in Q1 2026, little changed quarter-over-quarter from $5.5 million in Q4 2025.
Abeona Therapeutics (ABEO) Raw Materials (2025 - 2026) Analysis & Trends
Abeona Therapeutics' Raw Materials history runs 2 years deep, the most recent figure standing at $5.5 million for Q1 2026.
- On a quarterly basis, Raw Materials changed N/A year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $5.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.5 million, changed N/A from the prior year.
- Raw Materials steadied at $5.5 million in Q1 2026 per ABEO's latest filing, from $5.5 million in the prior quarter.
- Across five years, Raw Materials topped out at $5.5 million in Q1 2026 and bottomed at $5.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.50 Mn |
| Dec 31, 2025 | 5.49 Mn |